MedPath

EarLens Corporation

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 1
1 (33.3%)

The EarLens Contact Hearing Device (CHD) Spectrum Study

Not Applicable
Completed
Conditions
Hearing Loss, Sensorineural
First Posted Date
2015-06-12
Last Posted Date
2017-06-27
Lead Sponsor
EarLens Corporation
Target Recruit Count
46
Registration Number
NCT02470494
Locations
๐Ÿ‡บ๐Ÿ‡ธ

California Hearing and Balance Center, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Rodney Perkins Associates, Menlo Park, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Camino Ear Nose and Throat Clinic, San Jose, California, United States

and more 5 locations

The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study

Not Applicable
Completed
Conditions
Hearing Impairment
First Posted Date
2014-01-22
Last Posted Date
2016-02-02
Lead Sponsor
EarLens Corporation
Target Recruit Count
48
Registration Number
NCT02042404
Locations
๐Ÿ‡บ๐Ÿ‡ธ

EarLens Corporation, Menlo Park, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Camino Ear Nose and Throat Clinic, San Jose, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding

Phase 1
Completed
Conditions
Hearing Impairment
First Posted Date
2007-12-28
Last Posted Date
2016-11-04
Lead Sponsor
EarLens Corporation
Target Recruit Count
16
Registration Number
NCT00582946
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ear Lens Corporation, Redwood City, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.